1. A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment. Issue 11 (18th April 2022) Authors: Jiang, Yongluo; Wang, Yixing; Fu, Sha; Chen, Tao; Zhou, Yixin; Zhang, Xuanye; Chen, Chen; He, Li‐na; Du, Wei; Li, Haifeng; Lin, Zuan; Zhao, Yuanyuan; Yang, Yunpeng; Zhao, Hongyun; Fang, Wenfeng; Huang, Yan; Hong, Shaodong; Zhang, Li Journal: Thoracic cancer Issue: Volume 13:Issue 11(2022) Page Start: 1558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A large, single‐center, real‐world study of clinicopathological characteristics and treatment in advanced ALK‐positive non‐small‐cell lung cancer. (4th April 2017) Authors: Chen, Gang; Chen, Xi; Zhang, Yaxiong; Yan, Fang; Fang, Wenfeng; Yang, Yunpeng; Hong, Shaodong; Miao, Siyu; Wu, Manli; Huang, Xiaodan; Luo, Youli; Zhou, Cong; Gong, Run; Huang, Yan; Zhou, Ningning; Zhao, Hongyun; Zhang, Li Journal: Cancer medicine Issue: Volume 6:Number 5(2017:May) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China. Issue 1 (25th April 2016) Authors: Yang, Yunpeng; Ma, Yuxiang; Sheng, Jin; Huang, Yan; Zhao, Yuanyuan; Fang, Wenfeng; Hong, Shaodong; Tian, Ying; Xue, Cong; Zhang, Li Journal: Cancer communications Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China. Issue 1 (December 2016) Authors: Yang, Yunpeng; Ma, Yuxiang; Sheng, Jin; Huang, Yan; Zhao, Yuanyuan; Fang, Wenfeng; Hong, Shaodong; Tian, Ying; Xue, Cong; Zhang, Li Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors. (2nd May 2019) Authors: Ma, Yuxiang; Fang, Wenfeng; Zhang, Yang; Yang, Yunpeng; Hong, Shaodong; Zhao, Yuanyuan; Tendolkar, Amol; Chen, Lu; Xu, Dong; Sheng, Jennifer; Zhao, Hongyun; Zhang, Li Journal: Oncologist Issue: Volume 24:Number 7(2019) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma. (19th January 2020) Authors: Chen, Chen; Zhou, Yixin; Zhang, Xuanye; Fu, Sha; Lin, Zuan; Fang, Wenfeng; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Hong, Shaodong; Zhang, Li Journal: Cancer medicine Issue: Volume 9:Number 5(2020) Page Start: 1721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy. (August 2021) Authors: He, Li-Na; Fu, Sha; Zhang, Xuanye; Hu, Qiaozhen; Du, Wei; Li, Haifeng; Chen, Tao; Chen, Chen; Jiang, Yongluo; Zhou, Yixin; Lin, Zuan; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Fang, Wenfeng; Zhang, Li; Hong, Shaodong Journal: Lung cancer Issue: Volume 158(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Issue 10 (October 2018) Authors: Fang, Wenfeng; Yang, Yunpeng; Ma, Yuxiang; Hong, Shaodong; Lin, Lizhu; He, Xiaohui; Xiong, Jianping; Li, Ping; Zhao, Hongyun; Huang, Yan; Zhang, Yang; Chen, Likun; Zhou, Ningning; Zhao, Yuanyuan; Hou, Xue; Yang, Qing; Zhang, Li Journal: Lancet oncology Issue: Volume 19:Issue 10(2018) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combinatorial assessment of ctDNA release and mutational burden predicts anti‐PD(L)1 therapy outcome in nonsmall‐cell lung cancer. Issue 1 (6th May 2020) Authors: Fang, Wenfeng; Ma, Yuxiang; Yin, Jiani C.; Zhou, Huaqiang; Wang, Fufeng; Bao, Hua; Wang, Ao; Wu, Xue; Hong, Shaodong; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Shao, Yang W.; Zhang, Li Journal: Clinical and translational medicine Issue: Volume 10:Issue 1(2020) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma. Issue 3 (18th March 2021) Authors: Ma, Yuxiang; Chen, Xi; Wang, Ao; Zhao, Hongyun; Lin, Qingguang; Bao, Hua; Zhang, Yang; Hong, Shaodong; Tang, Wanxiangfu; Huang, Yan; Yang, Yunpeng; Wu, Xue; Shao, Yang; Fang, Wenfeng; Zhang, Li Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗